background
share
genom
ident
sarscov
exhibit
similar
well
conserv
structur
therefor
antibodi
produc
sar
patient
dissimilar
evalu
sarscov
test
assay
detect
presenc
antibodi
tri
determin
time
appear
antibodi
test
serial
sera
patient
method
test
carri
use
elisa
total
antibodi
indirect
immunofluoresc
iifa
igm
igg
method
serial
sera
patient
confirm
infect
result
crossreact
seen
two
test
assay
sera
patient
detect
patient
day
onset
symptom
five
patient
detect
antibodi
rd
week
ill
evid
seroconvers
patient
iifa
method
margin
sensit
compar
elisa
assay
howev
iifa
igm
test
use
earli
phase
ill
poor
sensit
conclus
exist
diagnost
assay
sarscov
detect
antibodi
patient
diagnos
assay
mayb
util
interim
measur
epidemiolog
investig
contact
trace
determin
extent
commun
spread
new
emerg
viru
pend
avail
specif
serolog
test
new
zoonot
coronaviru
cov
emerg
wuhan
china
first
report
st
decemb
number
case
increas
urgent
need
understand
outbreak
look
set
spread
sever
countri
around
world
total
number
case
probabl
gross
underestim
patient
may
present
symptom
common
cold
therefor
remain
undiagnos
due
mild
natur
ill
major
poorer
resourc
countri
may
also
capabl
equip
complex
molecular
diagnost
setup
thu
outbreak
area
may
go
undetect
time
number
case
report
sarsrel
viru
genom
ident
sarscov
similar
two
virus
describ
comprehens
recent
publish
articl
xu
et
al
structur
protein
includ
nucleocapsid
n
matrix
envelop
e
high
withingroup
conserv
maintain
modest
similar
seen
across
entir
cov
famili
contrast
accessori
protein
distinguish
cov
infect
high
variabl
across
famili
allow
virus
adopt
current
novel
host
studi
describ
differ
amino
acid
substitut
differ
protein
compar
sarscov
found
substitut
occur
nonstructur
protein
envelop
matrix
accessori
protein
n
protein
similar
amino
acid
ident
sarcov
n
protein
henc
antibodi
n
protein
would
like
recogn
bind
sarscov
n
protein
well
furthermor
studi
zhou
et
al
show
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
could
crossneutr
hors
antisarscov
serum
dilut
identifi
posit
case
confirm
molecular
test
respiratori
specimen
realtim
rtpcr
accord
publish
protocol
corman
et
al
retriev
residu
sampl
left
biochem
test
obtain
serial
sera
patient
biochemistri
depart
remov
patient
identifi
assign
random
number
patient
also
includ
number
day
onset
ill
retriev
specimen
base
inform
obtain
infecti
diseas
team
neg
control
sampl
sent
unrel
virolog
test
differ
group
patient
randomli
select
first
group
consist
sera
collect
year
ago
archiv
group
anoth
sera
patient
test
neg
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
two
occas
part
enhanc
surveil
patient
present
pneumonia
fulfil
criteria
suspect
infect
outbreak
period
perform
two
serolog
test
method
select
sampl
use
sarscov
total
patient
confirm
admit
institut
studi
period
total
sampl
retriev
biochemistri
depart
number
sampl
obtain
patient
rang
mean
earliest
taken
day
onset
symptom
latest
day
five
specimen
exclud
due
narrow
interv
sampl
close
proxim
date
onset
ill
figur
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
show
overal
iifa
test
sensit
elisa
test
explain
result
day
although
overal
result
iifa
test
may
sensit
iifa
igm
test
patient
found
less
use
detect
acut
phase
ill
consist
find
studi
sarscov
patient
found
less
frequent
robust
less
discriminatori
igm
respons
howev
gener
differ
assay
differ
perform
depend
type
antigen
util
countri
realtim
rtpcr
remain
diagnost
tool
choic
acut
phase
infect
given
antibodi
take
time
develop
onset
ill
serolog
test
would
use
present
earli
healthcar
facil
look
evid
previou
exposur
viru
relev
contact
trace
determin
true
extent
circul
viru
establish
accur
casefat
rate
possibl
posit
antibodi
test
could
result
previou
exposur
sar
year
ago
howev
given
case
report
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
worldwid
viru
known
still
circul
commun
declar
contain
report
case
probabl
seem
small
exclud
specif
histori
take
limit
studi
includ
rel
small
number
patient
inconsist
seri
sera
ideal
collect
predetermin
regular
time
interv
determin
igm
igg
detect
infect
assay
also
take
account
factor
could
caus
delay
develop
conclus
provid
proof
concept
avail
sarscov
antibodi
assay
reliabl
detect
antibodi
patient
could
use
current
outbreak
situat
serosurvey
diagnost
tool
resourc
countri
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
studi
would
requir
confirm
util
better
determin
time
frame
igm
igg
detect
patient
expos
acknowledg
would
like
thank
biochemistri
depart
help
retriev
blind
specimen
infecti
diseas
team
provid
onset
date
ill
pertin
meaning
interpret
result
